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ABSTRACT 
Cyclophilin (TcCyP19), a peptidyl-prolyl cis/trans isomerase, is a key molecule 
with diverse biological functions that include roles in molecular chaperoning, stress 
response, immune modulation, and signal transduction. In this respect, TcCyP19 could 
serve as a potential drug target in disease-causing parasites. Previous studies employing 
proteomics techniques have shown that the TcCyP19 isoform was more abundant in a 
benznidazole (BZ)-resistant Trypanosoma cruzi population than in its susceptible 
counterpart. In this study, TcCyP19 has been characterized in BZ-susceptible and BZ-
resistant T. cruzi populations. Phylogenetic analysis revealed a clear dichotomy between 
Cyphophilin A (CyPA) sequences from trypanosomatids and mammals. Sequencing 
analysis revealed that the amino acid sequences of TcCyP19 were identical among the 
T. cruzi samples analyzed. Southern blot analysis showed that TcCyP19 is a single-copy 
gene, located in chromosomal bands varying in size from 0.68 to 2.2 Mb, depending on 
the strain of T. cruzi. Northern blot and qPCR indicated that the levels of TcCyP19 
mRNA were two-fold higher in drug-resistant T. cruzi populations than in their drug-
susceptible counterparts. Similarly, as determined by two-dimensional gel 
electrophoresis immunoblot, the expression of TcCyP19 protein was increased to the 
same degree in BZ-resistant T. cruzi populations. No differences in TcCyP19 mRNA 
and protein expression levels were observed between the susceptible and the naturally 
resistant T. cruzi strains analyzed. Taken together, these data indicate that cyclophilin 
TcCyP19 expression is up-regulated at both transcriptional and translational levels in T. 
cruzi populations that were in vitro-induced and in vivo-selected for resistance to BZ. 
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1. Introduction  
Chagas disease, also known as American trypanosomiasis, is caused by the 
protozoan parasite Trypanosoma cruzi. It is estimated that 8 to 11 million people are 
infected with Chagas disease worldwide, mostly in Latin America, where it is endemic 
(CDC 2013). Drug treatment of chagasic patients currently involves the 5-nitrofuran 
nifurtimox (NFX) and the 2-nitroimidazole Benznidazole (BZ). However, both drugs 
cause severe side effects. NFX exerts its action via the generation of nitro anion 
radicals, a process known as the redox cycle (Maya et al., 2003), while BZ acts via 
reductive stress, which involves the covalent modification of macromolecules such as 
DNA, proteins, and lipids by reduced nitro intermediates (Docampo, 1990).  
A previous study suggests that both BZ and NFX are prodrugs, activated by 
nitroreductases to produce nitrogenated radicals (Wilkinson et al., 2008). Interestingly, 
the deletion of copies of genes encoding two different nitroreductases, namely, old 
yellow enzyme (TcOYE; also named prostaglandin synthase or NADPH 
oxidoreductase) (Murta et al., 2006) and trypanosomal type I nitroreductase (NTR-1) 
(Wilkinson et al., 2008), has been associated with a phenotype of T. cruzi, which is 
resistant to NFX and BZ in vitro. Overexpression of enzymatic activity related to 
antioxidant response, like that of tryparedoxin peroxidase, ascorbate peroxidase, and 
iron-superoxide dismutase, has been detected in T. cruzi populations resistant to BZ 
(Nogueira et al., 2006, 2009, 2012). In addition, the hexose transporter activity was 40% 
lower in a BZ-resistant T. cruzi population than in the susceptible control (dos Santos et 
al., 2012). Differences in susceptibility to BZ and NFX between T. cruzi strains (Filardi 
and Brener, 1987; Murta et al., 1998; Toledo et al., 2004) and/or the genetic diversity of 
the host (Filardi and Brener, 1987) might explain, in part, the variations in the efficacies 
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of antiparasitic drugs. The mechanisms underlying drug resistance in T. cruzi and most 
parasites remain poorly understood. A more in-depth understanding of these 
mechanisms is essential to develop efficacious chemotherapeutic strategies for fighting 
Chagas disease.  
Several groups have used proteomics approaches in order to understand the 
mechanisms of drug resistance in protozoan parasites. In a previous study by our group, 
two-dimensional electrophoresis in combination with mass spectrometry was applied to 
detect differences in protein expression between BZ–susceptible and -resistant T. cruzi 
populations, as well as variant clones (Andrade et al., 2008). Among the proteins 
upregulated in BZ-resistant samples, we observed that cyclophilin TcCyP19 was more 
abundant in the BZ-resistant population (17LER) and clone (27R) than in their BZ-
susceptible counterparts (17WTS and clone 9S). 
Cyclophilin (TcCyP19) is considered an important player in several biological 
processes like signal transduction, protein-protein interaction, as well as protein folding 
and cellular stress response (Galat, 2003). This protein belongs to the peptidyl-prolyl 
isomerase family (PPIases), which catalyzes the cis-trans isomerization of prolyl-
peptide bonds in biochemical pathways of cellular communication. The role of 
Cyclophilin (CyP) in heat shock response, in which the expression of a certain class of 
cyclophilins was shown to be upregulated under various stressful conditions, has been 
reviewed previously (Andreeva et al., 1999). The cyclophilin family comprises several 
isoforms, including cyclophilin TcCyP19, ranging in size from 19 to 110 kDa (Potenza 
et al., 2006). The most abundantly expressed cyclophilin in the epimastigote stage of T. 
cruzi is TcCyP19. This isoform is a classical cytosolic cyclophilin, with a theoretical 
mass of 18.782 Da (19 kDa). Búa and co-workers (2001) observed that TcCyP19 is 
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homologous to cyclophilin from T. brucei (TbCyP19), Leishmania major (LmCyP19), 
and T. vivax (TvCyP19). It has been reported that TcCyP19 and other cyclophilin 
members of T. cruzi (e.g., TcCyP22, TcCyP28, and TcCyP40) are also able to bind to 
the immunosuppressant drug cyclosporine A (CsA), which could serve to explain their 
role in mediating immunosuppressive responses (Potenza et al., 2006). Despite its 
multiple roles, the involvement of TcCyP19 in the BZ-resistant phenotype of T. cruzi 
has not yet been demonstrated.  
In the present study, the phylogenetic relationship between TcCyP19 and CyPs 
from other organisms was established, TcCyP19 nucleotide and amino acid sequence 
polymorphisms were evaluated, the copy number and chromosomal location of 
TcCyP19 gene was determined, and the expression of TcCyP19 gene was analyzed at 
the transcriptional and translational levels. We observed a positive correlation between 
increased expression of TcCyP19 in T. cruzi populations with in vitro-induced and in 
vivo-selected resistance to BZ.  
 
2. Materials and methods  
2.1 Trypanosoma cruzi strains 
Eleven T. cruzi strains and clones were used in this study (Table I). The BZ-
resistant T. cruzi population (17 LER) derived from the Tehuantepec cl2 susceptible 
wild-type strain (17 WTS) (Nirdé et al., 1995) was obtained by in vitro exposure to 
increasing concentrations of BZ (LAFEPE Pharmaceutical Laboratory of the State of 
Pernambuco, Vitória de Santo Antão, Brazil). Parasites of the 17 LER population are 
resistant to 220 µM BZ, a concentration that is 23-fold higher than the IC50 for the 17 
WTS control population. The BZ-resistant T. cruzi population (BZR) was derived from 
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the susceptible Y strain (BZS) following in vivo selection after 25 successive passages 
in mice treated with a single high dose (500 mg/kg body weight) of BZ (Murta and 
Romanha, 1998). We also used two clones derived from these populations: one 
susceptible (clone 9S) and other resistant (clone 27R). The other five T. cruzi strains 
were previously characterized according to their in vivo susceptibility to BZ and NFX 
(Filardi and Brener, 1987). The VL-10 strain is naturally resistant to both drugs, while 
CL Brener, Romano, Buriti and Berenice are susceptible (Murta et al., 1998). All eleven 
strains were classified as T. cruzi group Tc I, Tc II or Tc VI according to the 
nomenclature for T. cruzi (Zingales et al., 2009). Epimastigotes forms of all T. cruzi 
strains were grown in LIT medium, washed in PBS and the parasite pellets were used 
for the preparation of DNA, RNA and protein samples. 
 
2.2. In silico and phylogenetic analysis of the TcCyP19 gene 
Similarity searches were carried out for complete TcCyP19 amino acid sequence 
(GenBank accession no. XM_816485) within five different T. cruzi genomes, using the 
Basic Local Alignment Search Tool (BLAST; National Center for Biotechnology 
Information). The genomes used for similarity search were CL Brener Esmeraldo_Like, 
CLBrener Non-Esmeraldo_like, SylvioX10, JRc14 and Marinkellei_B7 (available in 
TritrypDB - www.tritrypdb.org - version 6.0). The sequences with high identity values 
to TcCyP19 were located within the respective genomes and the predicted proteins were 
identified using the ARTEMIS (version 15.0 - www.sanger.ac.uk) and BLAST. For 
phylogenetic analysis, the predicted protein sequences corresponding to cyclophilins 
were aligned using CLUSTAL-W (Larkin et al., 2007), and the phylogenetic tree was 
constructed using the MEGA software (Molecular Evolutionary Genetics Analysis, 
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version 5.2.2 – Tamura et al., 2011) with bootstrap test (1000 replicates). In addition, 
the amino acid sequence from TcCyP19 was compared with related cyclophilin 
sequences from four species of Trypanosoma (T. brucei, T. congolense, T. evansi and T. 
vivax), five Leishmania (L. donovani, L. infantum, L. major, L. mexicana and L. 
braziliensis), and two mammals (Mus musculus, and Homo sapiens). A phylogenetic 
tree for this second multialignment was also constructed using the MEGA software. 
 
2.3. RNA and DNA preparations 
Genomic DNA and total RNA from T. cruzi samples were extracted as previously 
described (Nogueira et al., 2006). In order to prepare the molecular probes used in the 
Southern and Northern blot assays, a 400 bp segment corresponding to nucleotide 68 to 
468 of the TcCyP19 (GenBank accession no. XM_816485) was amplified from T. cruzi 
Y strain DNA by conventional PCR using the TcCYP19 forward primer 5’ 
GGTGGCCAATCAGCCGGACG 3’ and the TcCYP19 reverse primer 5’ 
TCCATTGCCTTAACGACTTC 3’. For Southern blot assay, about 5 µg total DNA of 
different T. cruzi strains were digested with the restriction enzyme SacI in standard 
reaction conditions (Invitrogen, Carlsbad, CA, USA). The Southern and northern blots 
were carried out using protocol previously described (Murta et al., 2006). 
 
2.4. DNA sequencing 
The TcCyP19 534 bp ORF from T. cruzi BZ-susceptible and -resistant populations 
(17WTS, 17LER, BZS, BZR, CL Brener and VL-10) was cloned into the TOPO 
PCR2.1 vector (Invitrogen) and amplified in E. coli TOP 10 F’ competent cells. 
Minipreparations of plasmid DNA were done using the QIAprep Spin Miniprep kit 
8 
 
(Qiagen). Aliquots of 500 ng DNA were sequenced using the DYEnamic WET Dye 
Terminator Kit (GE Healthcare) in a MegaBACE 1000 DNA Analysis System (GE 
Healthcare), using the following primers: M13 forward 5'-GTAAAACGACGGCCAG-
3', M13 reverse 5'-CAGGAAACAGCTATGAC-3' and TcCyP19 forward 5'-
ATGTCGTACAAGCCGCATCA-3' and TcCyP19 reverse 5'-
AGGCCTCTGGTCAACTTTAA-3'. Reaction consisted of an initial denaturation at 
95°C followed by 30 cycles of 15s 95°C, 20s at 55°C and 80s at 60°C. Samples were 
analyzed on Mega Bace 400 sequencer (Amersham) and the data were analyzed using 
Phred, Phrap and Consed. Sequence variability between parasites was assessed by 
sequencing three colonies of each T. cruzi population and by sequencing each colony 
twice with each primer. Sequences selected for analysis were those with Phred >40. 
Nucleotide sequences were translated into the amino acid sequence using Transec. The 
nucleotide and amino acid sequences were aligned using the ClustalW 2.1 software. 
 
2.5. Pulsed Field Gel Electrophoresis (PFGE) 
The T. cruzi chromosomes were separated by PFGE in a gene navigator TM 
system (Amersham Pharmacia, Buckinghamshire, UK), as previously described (Murta 
et al. 2006). After testing different electrophoresis conditions and switch times, the best 
condition that provided the optimal separation for TcCyP19 gene was: 70 s for 15 h, 90 
s for 24 h, 200 s for 15 h, and 400 s for 15 h at 180 V. After electrophoresis, the gels 
were transferred onto Hybond nylon membranes (Amersham) as described by the 
manufacturer’s instructions. The membranes were hybridized with the 32P-labeled 
TcCyP19 gene probe.  
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2.6. Quantitative real-time RT-PCR 
The protocol employed for the preparation of first strand cDNA and the procedure 
for real-time RT-PCR were as previously described (Nogueira et al., 2006). An ABI 
Prism 7000 - Sequence Detection System SDS (PE Applied Biosystems, Foster City, 
CA, USA) was employed in the real-time PCR amplification of first strand cDNA (5 µl) 
using the specific primers: 5` TGTCGTACAAGCCGCATCAC 3` (RT CYPRTF 
forward) and 5` CAATGCTGACGTCGAAGAAGAC 3` (RT CYPRTR 2 reverse) 
selected from the complete nucleotide sequence of TcCyP19 (GenBank Accession No. 
XM_816485). The T. cruzi housekeeping gene hypoxanthine-guanine 
phosphoribosyltransferase (TcHGPRT) was used to normalize the amount of samples 
(Nogueira et al., 2006). Standard curves were prepared for each experiment using 
known quantities of TOPO PCR 2.1 plasmids (Invitrogen) containing the TcCyP19 and 
TcHGPRT genes. PCR products were quantified using Sequence Detection System data 
analysis software and normalized to the TcHGPRT values for each sample. 
 
2.7. Two-Dimensional Gel Electrophoresis (2-DE) and Western blotting analysis  
Protein extracts were obtained by direct lysis of parasites in lysis buffer 
(Matrangolo et al., 2013) in a proportion of 100 μl for 3.5 × 108 epimastigote forms. 
After extraction, protein concentration was quantified by the Bradford method. Protein 
extracts (100 µg) were loaded on 7 cm non-linear IPG strips pH 3–10 (Bio-Rad) and 
isoelectric focused using the Protean IEF Cell (Bio-Rad), 50 µA/strip at 20
o
C. Passive 
rehydration was performed for 4 h, followed by an active rehydration at 50 V for 12 h. 
Isoelectric focusing was increased gradually to 4,000 V and run for 16,000 V-hour. 
Subsequently, the second dimension electrophoretic protein separation was performed 
10 
 
in 12% SDS-PAGE and blotted onto nitrocellulose membranes. Blots were incubated 
for 16 h at 4C with rabbit polyclonal antibody anti-cyclophilin (TcCyP19) of T. cruzi 
(1:5,000) (kindly provided by Dr. Jacqueline Búa, Universidad de Buenos Aires, 
Argentina). The blots were washed and then incubated for 1 h with horseradish 
peroxidase-conjugated anti-rabbit IgG 1:2,000 (GE Healthcare). The blots were washed, 
incubated with ECL Plus chemiluminescent substrate (GE Healthcare) and exposed to 
X-ray film. To confirm equivalent loading, SDS-PAGE containing the same samples 
were stained with Colloidal Coomassie Blue G-250 (Neuhoff et al., 1988). The gels 
stained with Coomassie Blue G250 and the imumnoblots were scanned on a GS-800 
calibrated densitometer (BioRad) and submitted to comparative analysis. 
 
3. Results 
3.1. In silico and phylogenetic analysis of the TcCyP19 gene 
Similarity searches were carried out between the TcCyP19 sequence (GenBank 
accession XM_816485) and a local copy of the T. cruzi database of five different T. 
cruzi genomes. Altogether, 79 sequences similar to that of TcCyP19 were found in the 
five T. cruzi genomes (13 to 19 sequences were identified from each genome). The 
predicted protein sequence of the gene sequences identified was analyzed and compared 
to the NCBI non-redundant database, and 61 were found to share the highest similarity 
with cyclophilins. Of these, 24 proteins (including TcCyP19) had molecular weights 
ranging from 19 to 23 kDa, which is similar to the molecular weight of TcCyP19. A 
phylogenetic tree was constructed using these 24 cyclophilin sequences (ranging from 
18.7 to 23.7 kDa). A cyclophilin having a molecular weight of 35 kDa was used as the 
outgroup (Fig. 1S - supplementary data). The results showed that these cyclophilins 
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were grouped into two divergent branches. One of the branches included cyclophilins 
having molecular weights of 18.7 kDa (TcCyP19), 21.4–23.7 kDa, and 21.0–21.1 kDa, 
while the other encompassed cyclophilins having molecular weights of 21.6–21.7 and 
19.7–19.8 kDa.  
In order to compare the similarity of the TcCyP19 amino acid sequence with 
cyclophilin-A (CyPA) sequences of different organisms, a neighbor-joining 
phylogenetic tree was constructed (Fig. 1). This phylogenetic tree shows a clear 
dichotomous divergence between trypanosomatids and mammalian CyPA sequences. 
The amino acid sequence of TcCyP19 is closely related to sequences from other species 
of Trypanosoma and Leishmania, sharing identities ranging between 84% and 90% and 
78% and 81%, respectively.  
 
3.2. Sequencing data  
DNA sequencing of the TcCyP19 gene from T. cruzi populations that were susceptible 
(CL Brener, 17WTS, and BZS), naturally resistant (VL-10), and with in vitro-induced 
(17 LER) and in vivo-selected (BZS) resistance to BZ was performed in order to 
investigate whether point mutations could be associated with the BZ-resistance 
phenotype. Multiple-sequence alignment of the TcCyP19 gene nucleotide sequences 
revealed three nucleotide mutations (positions 150, 261 and 390) that do not lead to 
amino acid substitutions (Fig. 2S - supplementary data). No association was found 
between nucleotide mutations and BZ-resistant phenotype. These three nucleotide 
mutations are strain-specific.  
 
3.3. Copy number of the TcCyP19 gene  
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Southern blot assays were carried out using samples of T. cruzi genomic DNA 
that had been digested with the endonuclease SacI; which has one restriction site within 
the reference TcCyP19 sequence (GenBank accession no. XM_816485). Hybridization 
of the blots of SacI-digested DNA with a TcCyP19-specific probe revealed two 
fragments of 7.8 and 1.5 Kb in all T. cruzi samples analyzed (Fig. 3S - supplementary 
data).  
The copy number ratio of the TcCyP19 gene per genome for the pair 
17WTS/17LER and BZS/BZR was also determined by real-time PCR. Considering that 
T. cruzi contains 0.33 pg of DNA (Moser et al., 1989) and that TcHGPRT is a single-
copy gene (Allen and Ullman, 1994), TcCyP19 copy numbers were estimated using 
200, 100, 50, and 25 ng of genomic DNA. It was found that the copy number ratio of 
the TcCyP19 gene was the same for 17WTS/17LER and BZS/BZR populations (data 
not shown), indicating that the copy number of the TcCyP19 gene is not different in the 
genome of BZ-resistant T. cruzi populations.  
 
3.4. Chromosomal location of the TcCyP19 gene  
Chromosomes from T. cruzi strains were separated by pulsed-field gel 
electrophoresis (PFGE) (Fig. 2A). Chromosome hybridization with the TcCyP19-
specific probe showed that this gene is present in chromosomal bands that range from 
680 to 2200 kb (Fig. 2B). A correlation between the chromosomal location of the 
TcCyP19 gene and T. cruzi group was observed for the T. cruzi strains analyzed in this 
study (Table I). However, no correlation between chromosomal location of the 
TcCyP19 gene and the drug-resistant phenotype was established.  
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3.5. Levels of TcCyP19 mRNA expression 
Levels of TcCyP19 mRNA in the parasite populations were first investigated by 
northern blot analysis. A 1.4-kb transcript was detected in northern blots of total RNA 
derived from BZ-susceptible and -resistant T. cruzi strains, following hybridization with 
a 
32
P-labelled TcCyP19-specific probe (Fig. 3A). Quantitative controls using a 
ribosomal RNA probe are shown in Fig. 3B. Comparative densitometric analysis 
revealed that TcCyP19 mRNA levels were at least 2-fold higher in BZ-resistant 17LER 
and BZR populations than in their susceptible counterparts 17WTS and BZS. We did 
not observed any comparative difference in the levels of TcCyP19 mRNA among other 
T. cruzi strains and clones analyzed.  
TcCyP19 mRNA levels were complementarily determined by quantitative real-
time RT-PCR to confirm the northern blot results. The amount of TcCyP19 cDNA in 
the samples of T. cruzi was normalized by the single-copy housekeeping gene 
TcHGPRT, used as an internal reference. The results, shown in Fig 3C, indicate that the 
levels of transcription of the TcCyP19 gene were 2-fold higher in the 17LER and BZR 
populations compared to that in the 17WTS and BZS populations. No differences in the 
levels of transcription of the TcCyP19 gene were detected between the other T. cruzi 
BZ-susceptible and -resistant sample pairs, i.e., CL Brener versus VL-10.  
 
3.6. Levels of TcCyP19 protein expression  
2-DE western blotting analysis showed that the anti-TcCyP19 polyclonal antibody 
recognized two spots with the expected size of 19 kDa and an isoelectric point (pI) of 
7.0 to 8.5 in the pair 17LER/17WTS and three spots in the BZR/BZS pair (Fig. 4A), 
which coincides with that for TcCyP19. These spots, with pI values ranging from 7.0 to 
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8.5, correspond to the different isoforms of TcCyP19, probably owing to post-
translational modifications of the protein (Fig. 4). These findings confirm the protein 
identity and are suggestive of post-translational modifications of TcCyP19. According 
to the relevant literature, cyclophilin-A of L. infantum has one site of acetylation, 
justifying the occurrence of isoforms with more acidic pI (Rosenzweig et al., 2008). In 
fact, the polyclonal antibody anti-TcCyP19 might recognize TcCyP19 and other 
cyclophilin isoforms of similar molecular weight but different isoelectric points. 
Comparative analysis between Coomassie Blue-stained protein profiles of 
BZS/BZR and 17WTS/17LER T. cruzi populations showed that the protein load was 
similar between the samples tested (Fig. 4A and 4C). We selected the same region of 
both the Coomassie Blue-stained gels of 17WTS/17LER and BZS/BZR to perform the 
densitometric analysis. In this analysis, the protein expression of spots recognized by 
anti-TcCyP19 antibody was compared between the 17WTS/17LER and BZS/BZR pairs 
and normalized using the Coomassie Blue-stained protein profile. Densitometric 
analysis of the spots showed that the levels of protein expression of the two spots were 
higher in the 17LER BZ-resistant population than in its susceptible counterpart, i.e., 17 
WTS. In the BZS/BZR populations, we identified three spots as cyclophilin TcCyP19. 
One of them had higher expression levels in the BZS population, while the other two 
were more highly expressed in the BZ-resistant population BZR than in the susceptible 
population 17WTS (Fig. 4).  
In addition, we comparatively assessed the TcCyP19 protein expression of a BZ-
susceptible T. cruzi strain (CL Brener) and that of a T. cruzi strain (VL-10) naturally 
resistant to BZ, using western blot one-dimensional gel electrophoresis (1D). No 
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differences were observed in the expression levels of TcCyP19 protein between both the 
T. cruzi strains analyzed (data not shown). 
 
4. Discussion  
Cyclophilin-A is a member of the peptidyl-prolyl cis/trans isomerase class of 
enzymes and it is a key molecule in diverse biological processes, including molecular 
chaperoning, protein folding, and protein trafficking (Bell et al., 2006). In the present 
study, the gene encoding TcCyP19 was characterized from populations and strains of T. 
cruzi that are susceptible or resistant to benznidazole (BZ). The ORF of TcCyP19 
(TcCLB.506925.300) is 534 bp in length and encodes a protein of 177 amino acids, 
with a predicted mass of 19 kDa. Phylogenetic analyses of the amino acid sequences of 
CyPs revealed a clear dichotomy between trypanosomatid and mammalian cyclophilin 
sequences. CyP19 proteins from Trypanosoma spp. and Leishmania spp. are the closest 
related groups in this family. In addition, sequence analysis revealed that the amino acid 
sequences of the TcCyP19 protein are identical among the T. cruzi samples analyzed. 
Southern blot analysis showed that the TcCyP19 gene is present in the parasite 
genome as a single copy in BZ-resistant and -susceptible T. cruzi populations. These 
data are concordant with the results of a study by Potenza et al. (2006), who reported the 
presence of a single copy for each of the TcCyP genes analyzed in the T. cruzi genome 
(i.e., TcCyP19, TcCyP20, TcCyp22, TcCyP25, TcCyP28, TcCyP34, and TcCyP40). In 
the present study, the TcCyP19 gene was located in chromosome bands varying in size 
from 0.68 to 2.2 Mb, depending on the strain of T. cruzi. In partial agreement, Búa and 
co-workers (2001) observed that the TcCyP19 gene is located in two chromosomal 
bands of sizes 2.0 and 2.2 Mb in the CL Brener T. cruzi clone, whereas other 
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cyclophilin isoforms are found dispersed in the T. cruzi genome. These differences 
could be due to T. cruzi chromosomal rearrangements or cyclophilin-like sequences that 
could be recognized by the TcCyP19 probe. 
Northern blot and qPCR indicated that the levels of TcCyP19 mRNA were two-
fold higher in T. cruzi populations with in vitro-induced and in-vivo selected resistance 
to BZ compared to that in drug-susceptible counterparts. In accordance with these 
results, analytical 2DE immunoblot showed an increase in TcCyP19 protein expression 
level in the BZ-resistant T. cruzi populations. However, no differences in TcCyP19 
mRNA and protein expression levels were observed between the susceptible and 
naturally resistant T. cruzi strains analyzed, indicating different drug resistance 
mechanisms in these samples. Many studies evaluating drug resistance mechanisms in 
parasites were based on models produced by artificial induction of resistance. In 
contrast, there is very little information available on the biochemical mechanisms 
underlying drug resistance in field isolates. The data presented here show that TcCyP19 
protein expression level is increased in T. cruzi populations that were in vitro-induced 
and in-vivo selected for resistance to BZ, a situation that is different from that observed 
in the naturally resistant population. In agreement with our results, Villareal et al. 
(2005) observed that the mechanisms associated with natural resistance to drugs differ 
from those associated with induced resistance. The mechanism of drug resistance, such 
as that to BZ, is often complex and multifactorial, including molecules associated with 
the host immune system, which may interfere with the susceptibility of the parasite to 
the drug (Murta et al., 1999). Studies to determine whether overexpression of TcCyP19 
in the susceptible population will confer the BZ-resistant phenotype to these parasites 
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are required to confirm our hypothesis that TcCyP19 may be involved in T. cruzi 
resistance to BZ. 
Interestingly, in the presence of BZ or other stress conditions, an increase in the 
expression of several proteins of distinct biological function is observed. Consequently, 
TcCyP19 might contribute to counteract the chemical stress stimulus by increasing, for 
example, the activity of protein folding, which is necessary for efficient expression of 
functional polypeptides. The correlation between drug resistance and increased 
chaperonin activity has been observed in L. donovani (Kumar et al., 2010) and T. cruzi 
(Andrade et al., 2008). Interestingly, CyPA also has a protective role in murine cells, 
functioning as an antioxidant against oxidative stress (Doyle et al., 1999; Hong et al., 
2004). Additionally, in humans, CyPA binds peroxiredoxins, thereby increasing the 
peroxidase activity by their ability to transfer electrons (Lee et al., 2001). In analogy to 
this role, our data are indicative that the increased expression of TcCyP19 could in turn 
favor the expression and activity of enzymes associated with antioxidant defense 
(Nogueira et al., 2006, 2009, 2012). This might serve in detoxifying the parasite and 
might confer BZ-resistance — a hypothesis that warrants further investigation. 
Cyclophilin-A is also implicated in biological processes such as tumor resilience 
and progression. For instance, microarray analysis has shown that CyPA can upregulate 
the expression of cytokines and genes related to drug resistance (Chen et al., 2008). 
Furthermore, it was observed that elevated CyPA expression contributes to the drug-
resistance phenotype in cancer cells (Yang et al., 2011). Another study revealed that the 
overexpression of CyPA could promote cancer cell proliferation, cell 
migration/invasion, apoptosis inhibition, and drug-resistance phenotype in various 
cancer cell types (Obchoei et al., 2009). These data suggest that CyPA is a good target 
18 
 
for cancer chemotherapy. Interestingly, some studies suggest that TcCyPs are promising 
targets for the treatment of Chagas disease (Búa et al., 2008; Carraro et al., 2007). 
Cyclophilins bind cyclosporin A (CsA), an immunosuppressive antimicrobial drug, and 
non-immunosuppressive CsA analogues possess higher activity against T. cruzi (Búa et 
al., 2008). In conclusion, given that our results show that TcCyP19 is upregulated in 
BZ-resistant T. cruzi populations and that several lines of evidence implicate CyPs as a 
promising chemotherapeutic target against cancer and parasitic diseases, our work 
constitutes a starting point for further investigation into the role of TcCyPs in the 
mechanism of drug resistance and as a target for Chagas disease chemotherapy.  
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Fig. 1: Neighbour-joining phylogenetic tree of CyPs sequences of Trypanosoma cruzi 
and other organisms with a high similarity degree. The numbers shown are bootstrap 
values. Bootstrap is a method that provides assessments of confidence for each clade of 
an observed tree, based on the proportion of bootstrap trees showing that same clade 
(Efron et al., 1996). 
 
Fig. 2: Chromosomal location of the TcCyP19 gene in BZ-resistant and susceptible T. 
cruzi strains. (A) Chromosomal bands from the T. cruzi strains were separated by PFGE 
and stained with ethidium bromide. (B) Southern blots of the chromosomes were 
hybridised with a 
32
P-labeled TcCyP19-specific probe. Whole chromosomes from 
Saccharomyces cerevisae were used as molecular weight markers 
 
Fig. 3: Levels of TcCyP19 mRNA in BZ-resistant and susceptible T. cruzi strains. (A) 
Northern blot profile of total RNA extracts from the T. cruzi strains obtained using a 
32
P-labeled TcCyP19 -specific probe. (B) The quantitative control was used agarose gel 
containing the RNA, stained with ethidium bromide. (C) Number of cDNA molecules 
(copy number ratio) of TcCyP19 (x 10
6
). Values were normalized to those obtained for 
the TcHGPRT and are presented as the means (± S.D.M.) of triplicate real-time RT-PCR 
analyses from three independent experiments.  
 
Fig. 4: 2-DE gels of proteins and Western blot analysis of TcCyP19 expression in the 
benznidazole-susceptible and -resistant T. cruzi populations. Proteins (100 µg) were 
loaded on 7 cm, non-linear IPG strips of pH 3–10, submitted to isoelectric focusing and 
separated on 12% SDS-PAGE. The gels were stained with Colloidal Coomassie Blue 
G250 (A and C) or blotted onto nitrocellulose membranes (B and D). The blots were 
probed with a rabbit polyclonal antibody anti-cyclophilin-A of T. cruzi (1:5,000) and 
developed using ECL. 
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